Ident. | Authors (with country if any) | Title |
---|
000087 (2019) |
Z Beau Reneer [États-Unis] ; Ted M. Ross [États-Unis] | H2 influenza viruses: designing vaccines against future H2 pandemics. |
000160 (2018) |
Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie] | Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model. |
000176 (2018) |
Svetlana Shcherbik [États-Unis] ; Paul Carney [États-Unis] ; Nicholas Pearce [États-Unis] ; James Stevens [États-Unis] ; Vivien G. Dugan [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis] | Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines |
000212 (2018) |
Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Marina A. Shuklina [Russie] ; Eugenia S. Mardanova [Russie] ; Roman Y. Kotlyarov [Russie] ; Marina V. Potapchuk [Russie] ; Sergei A. Petrov [Russie] ; Elena A. Blokhina [Russie] ; Nikolai V. Ravin [Russie] | Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine. |
000264 (2017) |
Nicholas Wohlgemuth [États-Unis] ; Yang Ye [États-Unis] ; Katherine J. Fenstermacher [États-Unis] ; Hsuan Liu [États-Unis] ; Andrew P. Lane [États-Unis] ; Andrew Pekosz [États-Unis] | The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells. |
000283 (2017) |
Mizuho Suzuki ; Masatoshi Okamatsu ; Takahiro Hiono ; Keita Matsuno ; Yoshihiro Sakoda | Potency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice |
000318 (2017) |
Brian J. Lenny [États-Unis] ; Stephanie Sonnberg [États-Unis] ; Angela F. Danner [États-Unis] ; Kimberly Friedman [États-Unis] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] ; Jeremy C. Jones [États-Unis] | Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice |
000406 (2016) |
Wei Wang ; Esmeralda Alvarado-Facundo ; Qiong Chen ; Christine M. Anderson [États-Unis] ; Dorothy Scott [États-Unis] ; Russell Vassell ; Carol D. Weiss | Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses. |
000420 (2016) |
Nachiket Shembekar [Inde] ; Vamsee V Aditya Mallajosyula [Inde] ; Ankita Malik [Inde] ; Ashok Saini [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde] | Neutralization and Binding Profile of Monoclonal Antibodies Generated Against Influenza A H1N1 Viruses. |
000439 (2016) |
Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie] ; Xiyan Xu [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis] | Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses. |
000449 (2016) |
J Rgen De Jonge [Pays-Bas] ; Irina Isakova-Sivak [Russie] ; Harry Van Dijken [Pays-Bas] ; Sanne Spijkers [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Rineke De Jong [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Paul Roholl [Pays-Bas] ; Larisa Rudenko [Russie] | H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets. |
000497 (2015) |
E Y Boravleva ; I A Chvala ; N F Lomakina ; P I Repin ; N S Mudrak ; L G Rudenko ; A S Gambaryan ; V V Drygin | [Testing of apathogenic influenza virus H5N3 as a poultry live vaccine]. |
000499 (2015) |
Yu A. Desheva ; T A Smolonogina ; L G Rudenko | [A preclinical trial of the reassortant influenza virus vaccine strain A/17/Quail/Hong Kong/97/84 (H9N2)]. |
000505 (2015) |
Sarder Mohammed Asaduzzaman [Canada] ; Junling Ma [Canada] ; P. Van Den Driessche [Canada] | The coexistence or replacement of two subtypes of influenza. |
000531 (2015) |
Milton Thomas [États-Unis] ; Zhao Wang [États-Unis] ; Chithra C. Sreenivasan [États-Unis] ; Ben M. Hause [États-Unis] ; Gourapura J Renukaradhya [États-Unis] ; Feng Li [États-Unis] ; David H. Francis [États-Unis] ; Radhey S. Kaushik [États-Unis] ; Mahesh Khatri [États-Unis] | Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs. |
000533 (2015) |
Larisa Rudenko [Russie] ; Irina Isakova-Sivak | Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus. |
000550 (2015) |
José Vicente Pérez-Gir N ; Sergio G Mez-Medina ; Anja Lüdtke ; Cesar Munoz-Fontela [Allemagne] | Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity. |
000556 (2015) |
Xiaolan Yang [République populaire de Chine] ; Jianyu Zhao [République populaire de Chine] ; Cheng Wang [République populaire de Chine] ; Yueqiang Duan [République populaire de Chine] ; Zhongpeng Zhao [République populaire de Chine] ; Rui Chen [République populaire de Chine] ; Liangyan Zhang [République populaire de Chine] ; Li Xing [République populaire de Chine] ; Chengcai Lai [République populaire de Chine] ; Shaogeng Zhang [République populaire de Chine] ; Xiliang Wang [République populaire de Chine] ; Penghui Yang [République populaire de Chine] | Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge. |
000561 (2015) |
Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers |
000563 (2015) |
Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses. |
000566 (2015) |
Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Amanda Balish [États-Unis] ; Joyce Jones [États-Unis] ; Sharmi Thor [États-Unis] ; Charles Todd Davis [États-Unis] ; Melissa Pearce [États-Unis] ; Terrence Tumpey [États-Unis] ; David Cureton [États-Unis] ; Li-Mei Chen [États-Unis] ; Julie Villanueva [États-Unis] ; Tatiana L. Bousse [États-Unis] | Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation. |
000577 (2015) |
Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Victor V. Kuprianov [Russie] ; Elena A. Blokhina [Russie] ; Marina V. Potapchuk [Russie] ; Alexander V. Korotkov [Russie] ; Andrey N. Gorshkov [Russie] ; Marina A. Kasyanenko [Russie] ; Nikolai V. Ravin [Russie] ; Oleg I. Kiselev [Russie] | Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e. |
000600 (2015) |
Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie] | A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets. |
000602 (2015) |
Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James R. Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie] | A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets. |
000607 (2015) |
José Esteban Mu Oz-Medina [Mexique] ; Carlos Javier Sánchez-Vallejo [Mexique] ; Alfonso Méndez-Tenorio [Mexique] ; Irma Eloísa Monroy-Mu Oz [Mexique] ; Javier Angeles-Martínez [Mexique] ; Andrea Santos Coy-Arechavaleta [Mexique] ; Clara Esperanza Santacruz-Tinoco [Mexique] ; Joaquín González-Ibarra [Mexique] ; Yu-Mei Anguiano-Hernández [Mexique] ; César Raúl González-Bonilla [Mexique] ; Eva Ram N-Gallegos [Mexique] ; José Alberto Díaz-Qui Onez [Mexique] | In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential |
000652 (2014) |
Christopher D. O'Donnell [États-Unis] ; Leatrice Vogel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie] | The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines. |
000674 (2014) |
Andrew J. Broadbent [États-Unis] ; Celia P. Santos [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; Janine Lu [États-Unis] ; Zhongying Chen [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [États-Unis] | Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates |
000682 (2014) |
Svetlana V. Shcherbik [États-Unis] ; Nicholas C. Pearce [États-Unis] ; Marnie L. Levine [États-Unis] ; Alexander I. Klimov [États-Unis] ; Julie M. Villanueva [États-Unis] ; Tatiana L. Bousse [États-Unis] | Rapid strategy for screening by pyrosequencing of influenza virus reassortants--candidates for live attenuated vaccines. |
000691 (2014) |
Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche] | Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults |
000724 (2014) |
Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Xing Cheng [États-Unis] ; Fernando Torres-Velez [États-Unis] ; Marlene Orandle [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | Evaluation of Three Live Attenuated H2 Pandemic Influenza Vaccine Candidates in Mice and Ferrets |
000730 (2014) |
Irina Isakova-Sivak [Russie] ; J Rgen De Jonge [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Geert Van Amerongen [Pays-Bas] ; Harry Van Dijken [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Paul Roholl [Pays-Bas] ; Victoria Kuznetsova [Russie] ; Elena Doroshenko [Russie] ; Vadim Tsvetnitsky [États-Unis] ; Larisa Rudenko [Russie] | Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus |
000741 (2014) |
Irina Isakova-Sivak [États-Unis, Russie] ; Li-Mei Chen [États-Unis] ; Melissa Bourgeois [États-Unis] ; Yumiko Matsuoka [États-Unis] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Alexander Klimov [États-Unis] ; Larisa Rudenko [Russie] ; Nancy J. Cox [États-Unis] ; Ruben O. Donis [États-Unis] | Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model |
000747 (2014) |
Svetlana Shcherbik [États-Unis] ; Sheila B. Sergent ; William G. Davis ; Bo Shu ; John Barnes ; Irina Kiseleva ; Natalie Larionova ; Alexander Klimov ; Tatiana Bousse | Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production. |
000804 (2013) |
Wilfried Witte | [Pandemic without drama. Influenza vaccination and Asian flu in Germany]. |
000864 (2013) |
Wen He [République populaire de Chine] ; Wei Wang ; Huamin Han ; Lei Wang ; Ge Zhang ; Bin Gao | Molecular basis of live-attenuated influenza virus. |
000865 (2013) |
Manojkumar Ramanunninair [États-Unis] ; Jianhua Le [États-Unis] ; Shiroh Onodera [États-Unis] ; Andrew A. Fulvini [États-Unis] ; Barbara A. Pokorny [États-Unis] ; Jeanmarie Silverman [États-Unis] ; Rene Devis [États-Unis] ; Jennifer M. Arroyo [États-Unis] ; Yu He [États-Unis] ; Alex Boyne [États-Unis] ; Jayati Bera [États-Unis] ; Rebecca Halpin [États-Unis] ; Erin Hine [États-Unis] ; David J. Spiro [États-Unis] ; Doris Bucher [États-Unis] | Molecular Signature of High Yield (Growth) Influenza A Virus Reassortants Prepared as Candidate Vaccine Seeds |
000A23 (2012) |
Jianzhong Shi [République populaire de Chine] ; Zhiyuan Wen ; Jing Guo ; Ying Zhang ; Guohua Deng ; Yuelong Shu ; Dayan Wang ; Yongping Jiang ; Yoshihiro Kawaoka [États-Unis] ; Zhigao Bu ; Hualan Chen | Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice. |
000A27 (2012) |
Filippo Ansaldi [Italie] ; Laura Valle ; Daniela De Florentiis ; Valentina Parodi ; Giuseppe Murdaca ; Bianca Bruzzone ; Paolo Durando ; Maurizio Setti ; Giancarlo Icardi | Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. |
000A50 (2012) |
Nicola Clementi ; Elena Criscuolo ; Matteo Castelli ; Nicasio Mancini ; Massimo Clementi ; Roberto Burioni | Influenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines |
000A76 (2012) |
Alexandra S. Gambaryan [Russie] ; Natalia F. Lomakina ; Elizaveta Y. Boravleva ; Ekaterina A. Kropotkina ; Vadim V. Mashin ; Igor V. Krasilnikov ; Alexander I. Klimov ; Larisa G. Rudenko | Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine). |
000A85 (2012) |
Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta Subbarao | An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults |
000B91 (2011) |
I V Kiseleva ; J T M. Voeten ; L C P. Teley ; N V Larionova ; I A Dubrovina ; Zh A. Berdygulova ; E A Bazhenova ; H. Van Den Bosch ; J G M. Heldens ; L G Rudenko | [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine]. |
000B97 (2011) |
Guus F. Rimmelzwaan [Pays-Bas] ; Rogier Bodewes ; Albert D M E. Osterhaus | Vaccination strategies to protect children against seasonal and pandemic influenza. |
000C34 (2011) |
Yanwei Zhong [République populaire de Chine] ; Jiong Cai [République populaire de Chine] ; Chuanfu Zhang [République populaire de Chine] ; Xiaoyan Xing [République populaire de Chine] ; Enqiang Qin [République populaire de Chine] ; Jing He [République populaire de Chine] ; Panyong Mao [République populaire de Chine] ; Jun Cheng [République populaire de Chine] ; Kun Liu [République populaire de Chine] ; Dongping Xu [République populaire de Chine] ; Hongbin Song [République populaire de Chine] | Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A |
000C35 (2011) |
T V Chirkova [Russie] ; A N Naykhin ; G D Petukhova ; D A Korenkov ; S A Donina ; A N Mironov ; L G Rudenko | Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine. |
000C38 (2011) |
Larisa Rudenko [Russie] ; Han Van Den Bosch ; Irina Kiseleva ; Alexander Mironov ; Anatoly Naikhin ; Natalie Larionova ; Dimitry Bushmenkov | Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries. |
000C50 (2011) |
Penghui Yang [République populaire de Chine] ; Yueqiang Duan ; Cheng Wang ; Li Xing ; Xiao Gao ; Chong Tang ; Deyan Luo ; Zhongpeng Zhao ; Weihong Jia ; Daxin Peng ; Xiufan Liu ; Xiliang Wang | Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets. |
000C60 (2011) |
Irina Isakova-Sivak [États-Unis] ; Li-Mei Chen ; Yumiko Matsuoka ; J Theo M. Voeten ; Irina Kiseleva ; Jacco G M. Heldens ; Han Van Den Bosch ; Alexander Klimov ; Larisa Rudenko ; Nancy J. Cox ; Ruben O. Donis | Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). |
000C81 (2011) |
Kortney M. Gustin [États-Unis] ; Taronna R. Maines ; Jessica A. Belser ; Neal Van Hoeven ; Xuihua Lu ; Libo Dong ; Irina Isakova-Sivak ; Li-Mei Chen ; J Theo M. Voeten ; Jacco G M. Heldens ; Han Van Den Bosch ; Nancy J. Cox ; Terrence M. Tumpey ; Alexander I. Klimov ; Larisa Rudenko ; Ruben O. Donis ; Jacqueline M. Katz | Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. |
000C86 (2011) |
Chao Qiu ; Yang Huang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Di Tian ; Wanju Zhang ; Yunwen Hu ; Zhenghong Yuan ; Xiaoyan Zhang ; Jianqing Xu | Boosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine |
000C94 (2011) |
Nicola Clementi [Italie] ; Donata De Marco ; Nicasio Mancini ; Laura Solforosi ; Guisella J. Moreno ; Larisa V. Gubareva ; Vasiliy Mishin ; Andrea Di Pietro ; Elisa Vicenzi ; Antonio G. Siccardi ; Massimo Clementi ; Roberto Burioni | A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes. |